Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Solvay identifies potent, selective, orally active CB1 antagonist, initially targeted for psychosis

Sep. 6, 2002

Novel 5-HT2A/2C and H1 antagonist from Janssen with anxiolytic-like activity

Sep. 6, 2002

UCB-34714: a new levetiracetam analogue discovered at UCB

Sep. 6, 2002

Eplerenone for the long-term treatment of chronic heart failure

Sep. 6, 2002

Increase in weight associated with increased food consumption on olanzapine in mice

Sep. 5, 2002

Novel human neutrophil elastase inhibitor effective in animal models of acute organ injury

Sep. 5, 2002

IK-264 reduces body weight by suppressing appetite

Sep. 5, 2002

Functional and structural improvement seen in CHF dogs treated with ivabradine

Sep. 5, 2002

LU-135252 does not attenuate ischemia/reperfusion-associated arrhythmia

Sep. 5, 2002

Pharmacological characterization of novel, selective beta3-adrenoceptor agonist from Kissei

Sep. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...